VRPX — Virpax Pharmaceuticals Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Virpax Pharmaceuticals Inc Advances Envelta Development With Ncats Under Crada Agreement
Brief: Recro Pharma Awarded Development And Manufacturing Contract By National Institutes Of Health (Nih) To Support Novel Nasal Spray Analgesic
Brief: Virpax Pharmaceuticals Inc Signs Agreement With Sinclair Research To Initiate Investigational New Drug (IND)-Enabling Studies For Anqlar
Brief: Virpax Pharmaceuticals Inc To Develop Intranasal Cannabidiol Product To Manage Epilepsy In Adults And Children
U.S. STOCKS ON THE MOVE-Progenity, Fuelcell, Support.com
U.S. STOCKS ON THE MOVE-PAR Technology, RedHill, Fuelcell Energy
NASDAQ RESUMED AT 09:59 AM
Brief: Virpax Reports Pricing of $40 Mln Public Offering of Common Stock
NASDAQ TRADE HALT HALT NEWS PENDING AT 04:00 AM
Brief: Virpax Pharmaceuticals Inc Files For Offering 3.4 Mln Shares Of Common Stock On A Firm Commitment Basis
Virpax Pharmaceuticals jumps on supply agreement for anti-viral spray
Brief: Virpax Pharmaceuticals Announces Mms019 Manufacturing And Supply Agreement
NASDAQ RESUMED AT 09:53 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:49 AM
NASDAQ RESUMED AT 09:44 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:40 AM
Virpax Pharma leaps nearly fourfold on plan to develop spray against viruses
NASDAQ RESUMED AT 01:47 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:42 PM